ADHD Treatment Insurance Denied for Your Child? How to Appeal

Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurodevelopmental disorder in children, affecting approximately 9.4% of children ages 2–17 in the United States. Despite being a well-established diagnosis with evidence-based treatments endorsed by the American Academy of Pediatrics (AAP), insurance denials for ADHD medication Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization, behavioral therapy, and diagnostic evaluations are frequent. These denials are often based on administrative technicalities or overly restrictive clinical criteria — and most can be appealed successfully. The combination of AAP Clinical Practice Guidelines, federal mental health parity law (MHPAEA §1185a), and state step therapy override statutes gives families a powerful set of tools.

Why Insurers Deny ADHD Treatment for Children

ADHD treatment denials cluster around a few recurring issues that are worth identifying precisely before building your appeal.

• Prior authorization denied for stimulant or non-stimulant medication — The insurer requires step therapy (trying a generic formulation before a branded medication, or a stimulant before a non-stimulant) even when the pediatrician or psychiatrist has documented clinical reasons for a specific first-line agent. ICD-10 codes: F90.0 (predominantly inattentive type), F90.1 (predominantly hyperactive-impulsive type), F90.2 (combined type), F90.9 (unspecified).
• Step therapy not completed — Insurers deny extended-release formulations because cheaper immediate-release versions have not been tried first — even when the prescriber has documented a clinical reason to skip that step (abuse history, swallowing difficulties, school scheduling needs).
• Behavioral therapy classified as educational, not medical — Insurers deny Behavior Parent Training (BPT) or school-based behavioral interventions on the grounds that they are educational. The AAP 2019 CPG explicitly recommends behavioral therapy as first-line treatment for children ages 4–5 and as a complement to medication for all ages.
• Diagnostic evaluation not covered — Comprehensive neuropsychological testing or ADHD evaluations are denied as "not medically necessary" even when specialist evaluation is needed to guide treatment decisions.
• Not medically necessary for continued treatment — Insurers deny refills or ongoing behavioral therapy citing insufficient documentation of continuing need or treatment response.
• Mental health benefit exhausted or limited — The plan's separate mental health visit caps restrict behavioral therapy even when ADHD treatment is otherwise covered — potentially a MHPAEA violation.

How to Appeal an ADHD Treatment Denial

Step 1: Read the denial letter and identify the specific basis

Determine whether the denial is a prior authorization denial, step therapy denial, benefit exclusion, or medical necessity denial. Each requires a different approach. Request the insurer's CPB for ADHD treatment and the step therapy protocol before writing the appeal.

Step 2: Have the pediatrician or psychiatrist provide a detailed clinical letter

The letter should address: the specific ADHD diagnosis with ICD-10 code (F90.x); the clinical rationale for the specific treatment prescribed; documentation of any prior treatments tried; reasons for step therapy exception if applicable (adverse effects from generic formulation, inability to swallow tablets, specific pharmacological need); and citation of AAP 2019 Clinical Practice Guideline for ADHD supporting the prescribed treatment.

Step 3: Build the MHPAEA parity argument

Research whether your plan covers comparable medical conditions with comparable visit limits and step therapy requirements. If the plan caps behavioral therapy at 20 visits per year but covers unlimited physical therapy for musculoskeletal conditions, that asymmetry may be a MHPAEA §1185a violation. Document this comparison specifically and raise it in the appeal letter. For employer-sponsored plans, a parity violation complaint can be filed with the Department of Labor (EBSA).

Step 4: Request a step therapy override for medication denials

Many states have enacted step therapy override laws requiring insurers to grant exceptions when a prescriber documents clinical reasons for a non-preferred medication. Cite your state's step therapy law explicitly and provide the prescriber's written documentation of the clinical basis for the override.

Step 5: Write and file the internal appeal letter

Quote the insurer's denial criteria and demonstrate how the child's case meets those criteria, or why the criteria are more restrictive than AAP 2019 guidelines. Cite MHPAEA §1185a for parity arguments, ACA §2719 for procedural appeal rights, and ERISA §1133 for claims file access (employer plans). File within 180 days of the denial date.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">external review and file regulatory complaints

If the internal appeal is denied, request external review immediately. For MHPAEA parity violations, simultaneously file a complaint with the Department of Labor (employer plans) at dol.gov/agencies/ebsa or with your state insurance commissioner (fully insured plans). External reviewers applying clinical standards consistently support evidence-based ADHD treatment under AAP guidelines.

What to Include in Your Appeal

• Denial letter with specific denial reason, clinical criteria cited, and ICD-10 code (F90.0, F90.1, F90.2, or F90.9) confirmed on the claim
• Treating pediatrician or psychiatrist's letter of medical necessity citing AAP 2019 Clinical Practice Guideline for ADHD and addressing step therapy exception basis if applicable
• Prior treatment records: all medications tried, doses, duration, and documented adverse effects or inadequate response
• MHPAEA parity analysis comparing mental health benefit limitations (behavioral therapy visit caps) to comparable medical benefit limitations in the same plan
• State step therapy override law citation with prescriber's written documentation of clinical basis for the non-preferred medication

Fight Back With ClaimBack

ADHD treatment denials for children are among the most common — and most reversible — insurance denials. The combination of AAP guidelines, MHPAEA parity protections, and state step therapy override laws gives parents powerful tools. ClaimBack generates a professional appeal letter in 3 minutes, customized to your insurer's specific CPB criteria. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal